Seminoma - 65 Studies Found
Recruiting |
: A Prospective Study of Cabazitaxel in Patients With Non Seminomatous Germ-cell Tumors : Non-seminomatous Germ-cell Tumors : 2014-04-10 : Drug: Cabazitaxel On Day 1 of each cycle, patients will receive cabazitaxel at a dose of 25 mg/m², |
Active, not recruiting |
: Trial of 1 Cycle of Adjuvant BEP Chemotherapy in High Risk, Stage 1 Non-seminomatous Germ Cell Testis Tumours : Stage I Testicular Non-Seminomatous Germ Cell Tumor : 2012-11-09 : Drug: BEP(500) One cycle of BEP(500): |
Active, not recruiting |
: Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors : Germ Cell Tumor : 2005-08-03 : Drug: gemcitabine, ifosfamide, cisplatin, G-CSF |
Recruiting |
: Contribution of the Imaging to the Expression of intégrines αvβ3 for the Characterization of Residual Masses of Non-seminoma Tumors at the End of Chemotherapy :
: 2014-08-25 :
|
Recruiting |
: Combination Chemotherapy in Treating Patients With Stage II or Stage III Germ Cell Tumors :
|
Completed |
: Positron Emission Tomography in Detecting Testicle Cancer : Testicular Germ Cell Tumor : 2002-09-06 :
|
Completed |
: Follow-up Evaluation Using CT Scans in Patients Who Have Been Treated For Metastatic Testicular Cancer : Testicular Germ Cell Tumor : 2007-11-02 :
|
Completed |
: Diagnostic Study of Patients With Stage I Testicular Cancer : Testicular Germ Cell Tumor : 1999-11-01 :
|
Recruiting |
: First Line TIP in Poor Prognosis TGCTs. : Germ Cell Tumor : 2015-04-08 :
|
Recruiting |
: Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors :
: Drug: Brentuximab Vedotin Both cohorts will be treated similarly and in parallel but analyzed separately |